UPDATE : Monday, September 7, 2020
상단여백
‘Quarter of drugs winning fast-track approvals not supplied at all’ by Lee Hye-seon 2017-10-17 16:34
TissueGene promotes cell gene therapy Invossa ahead of IPO by Lee Hye-seon 2017-10-17 14:32
Mandatory drug labeling of all ingredients to start in December by Lee Hye-seon 2017-10-16 15:33
2 orphan drugs find manufacturers in Korea by Lee Hye-seon 2017-10-12 15:48
Boryung to sell antihypertensive drugs in SE Asia by Lee Hye-seon 2017-10-11 16:02
라인
Samsung Bioepis teams up with Yuhan for biosimilars by Lee Hye-seon 2017-10-11 14:25
Anticorruption law changes drugmakers, salespersons by Lee Hye-seon 2017-09-28 17:14
Korean combos, incrementally modified drugs to get insurance benefits by Lee Hye-seon 2017-09-27 11:29
72 drugs should warn against autoimmunity muscle disease by Lee Hye-seon 2017-09-25 15:30
Chong Kun Dang, Daewoong continue to fight over Gliatilin reference listed drug by Lee Hye-seon 2017-09-22 12:17
라인
Samsung Bioepis gets additional approval for its biosimilar by Lee Hye-seon 2017-09-21 12:03
Big data behind CJ’s development of new drug by Lee Hye-seon 2017-09-20 12:05
Prices of Viread's modified drugs plunge over past month by Lee Hye-seon 2017-09-19 17:22
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs by Lee Hye-seon 2017-09-18 11:26
Kolon uses Invossa to attract foreign patients by Lee Hye-seon 2017-09-15 17:49
라인
SK Chemicals’ release of test result abroad raises curiosity by Lee Hye-seon 2017-09-15 17:39
Hanmi releases research result of new bio drug in Europe by Lee Hye-seon 2017-09-15 14:32
LG Chem promotes antidiabetic Zemiglo in Europe by Lee Hye-seon 2017-09-15 11:51
Chong Kun Dang enters an osteoporosis therapy market by Lee Hye-seon 2017-09-14 17:53
Severance Hospital revamps emergency care center by Lee Hye-seon 2017-09-13 16:08
여백
여백
여백
Back to Top